fda warning bpc 157 not approved drug An Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition WATCH: FDA advisory panel narrowly
WATCH: FDA advisory panel narrowly backs use of several peptides favored by RFK Jr. Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA Advisory Panel Votes to Loosen Rules on BPC 157, TB 500, and MOTS C Despite Agency Scientists' Opposition FDA reviews BPC 157, TB 500 and other peptides favored by RFK Jr. AP News
Pay in 4 interest-free payments of $6.81 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15

